News and Events

Pancreatic and Hepatocellular Cancer Pathway Improvement Project (PHCC PIP) Evaluation

In December 2020, the Cabinet Secretary for Health and Sport announced the publication of a Cancer Action Plan for Scotland to drive a ‘Once for Scotland’ approach to cancer services, where this is appropriate. The plan sets out activities to improve equitable access to cancer care and treatment across Scotland. A Scottish Cancer Network (SCN) was established as a structure to lead and deliver a range of activities within the plan. Developments included the transfer to the SCN of support and governance for three well established National Managed Clinical Networks for cancers, including, the Scottish Hepatobiliary Network (SHPBN).

Action 45 of the plan sets out the ambition to improve pathways of less survivable cancers, particularly hepatocellular carcinoma and pancreatic cancer, with a view to shortening the time to staging and agreeing treatment plans. In support of this ambition Scottish Government funded a proposal through SHPBN for the Pancreatic and Hepatocellular Cancer Pathway Improvement Project (PHCC PIP) to pilot a national delivery model as a test of change to inform a future sustainable service model for a range of tumour sites. The project was scheduled from April 2022 to March 2024.

The purpose of this document is to provide a comprehensive review of the Pancreatic and Hepatocellular Pathway Improvement Project (PHCC PIP) that ran from 1 April 2022 to 31 March 2024.

Please click here for link to view PHCC PIP Evaluation document